Pre-formulation active ingredients and lyophilized bio-peptides tested under strict HPLC and Mass Spectrometry validation for Canadian laboratories.
An in-depth perspective on local biotechnology demand, research ecosystems, and direct factory procurement across Canadian provinces.
Canada boasts one of the most concentrated biomedical and life-science ecosystems in North America. Across major hubs including the Discovery District in Toronto, Montreal's Bio-Health Technology Corridor, and Vancouver's booming biotechnology belt, research centers are conducting extensive investigations into the mechanism of action of non-steroidal selective androgen receptor modulators (SARMs). These compounds—such as Enobosarm (Ostarine / MK-2866), Ligandrol (LGD-4033), Testolone (RAD-140), and auxiliary growth secretagogues like Ibutamoren Mesylate (MK-677)—serve as foundational molecules for investigating severe pathological conditions.
Canadian pre-clinical programs prioritize SARMs due to their high tissue selectivity: exhibiting pronounced anabolic activity in skeletal muscle tissue and osteoblastic bone matrices while demonstrating markedly attenuated stimulation of prostatic and seminal tissues. Laboratories associated with institutions like McGill University, the University of Toronto, and the University of British Columbia utilize high-purity raw powders to model the mitigation of cancer cachexia, end-stage renal disease (ESRD) muscle wasting, post-menopausal osteoporosis, and age-related sarcopenia.
Health Canada Regulatory Framework: In Canada, SARMs are classified as prescription drugs and controlled chemical substances when intended for human administration, regulated under the Food and Drugs Act. Domestic distribution or formulation for human consumption is prohibited without Health Canada market authorization (DIN/NPN). However, Canadian academic institutions, registered contract research organizations (CROs), and analytical laboratories are fully authorized to procure pure, bulk raw SARMs powder designated for In-Vitro Laboratory Research, Diagnostic Calibration, and Non-Clinical Animal Studies (RUO).
Despite vigorous pre-clinical demand, Canada possesses very few active domestic synthesis plants dedicated to small-molecule androgen receptor ligands. The capital-intensive nature of establishing fine-chemical multi-step organic synthesis infrastructure—combined with rigorous Canadian environmental emissions protocols, high labor overheads, and protracted zoning authorizations—has created a substantial reliance on international synthesis powerhouses. Consequently, Canadian life-science entities and chemical distributors require stable, reliable relationships with first-tier bulk chemical synthesis factories in China that maintain strict adherence to cGMP quality protocols, verified assay standards, and seamless international customs logistics.
By eliminating multiple layers of domestic North American brokers and chemical trading houses, Canadian enterprises save between 40% and 65% on bulk procurement expenses.
Every single batch export intended for the Canadian market is accompanied by comprehensive, unedited analytical documentation to guarantee zero cross-contamination.
Deep expertise in Canada Border Services Agency (CBSA) and international freight protocols ensuring smooth transit through Vancouver (YVR) and Toronto (YYZ) air hubs.
Behind the scenes of our cGMP fine-chemical synthesis workflows producing multi-kilogram batches of research-grade raw SARMs powder.
The manufacturing of non-steroidal androgen receptor modulators involves sophisticated, multi-stage chiral synthesis pathways. For compounds like MK-2866 (Ostarine) and LGD-4033 (Ligandrol), maintaining exact enantiomeric purity is essential. Stereochemical isomer deviations can drastically diminish receptor binding affinities ($K_i$) or produce off-target secondary interactions in pre-clinical biological models.
Our manufacturing facility leverages computerized glass-lined reaction kettles ranging from 50L to 1,000L capacity. The synthetic pathway integrates catalytic coupling, low-temperature cyclization, and successive recrystalization phases using high-grade solvents. To eradicate volatile solvent residues (such as dichloromethane, ethanol, and hexane), final-stage vacuum freeze-drying is deployed within cleanroom environments adhering to ISO Class 7 standards.
| Target Compound | Standard CAS No. | Chemical Formula | Typical HPLC Purity | Moisture Content (Karl Fischer) | Heavy Metals (ICP-MS) |
|---|---|---|---|---|---|
| MK-2866 (Ostarine / Enobosarm) | 841205-47-8 | C19H14F3N3O3 | ≥99.4% | ≤0.5% | <10 ppm |
| LGD-4033 (Ligandrol) | 1165910-22-4 | C14H12F6N2O | ≥99.2% | ≤0.4% | <10 ppm |
| RAD-140 (Testolone) | 1182367-47-0 | C20H16ClN5O2 | ≥99.5% | ≤0.5% | <5 ppm |
| MK-677 (Ibutamoren Mesylate) | 159752-10-2 | C27H36N4O5S·CH4O3S | ≥99.3% | ≤0.8% | <10 ppm |
| GW-501516 (Cardarine) | 317318-70-0 | C21H18F3NO3S2 | ≥99.6% | ≤0.3% | <5 ppm |
| YK-11 (Steroidal SARM) | 1370003-76-1 | C25H34O6 | ≥98.8% | ≤0.9% | <15 ppm |
The global scientific dialogue is steadily advancing toward combination regimens. In contemporary metabolic and oncological research, investigators frequently observe synergistic outcomes when combining tissue-selective androgen receptor modulators with bioactive growth hormone-releasing hexapeptides (such as CJC-1295, Sermorelin), natural myostatin inhibitors like Follistatin-344, or multi-incretin receptor agonists like Tirzepatide and Retatrutide. By supplying an integrated platform of pure raw SARMs powder alongside reference peptides, our manufacturing capability empowers Canadian institutions to streamline procurement through a single, audited supply partner.
Key technical, legal, and operational questions answered for Canadian procurement directors, research associates, and corporate importers.
Under Health Canada regulations and the Canadian Food and Drugs Act, raw SARMs powder can be legally imported by verified institutional researchers, academic laboratories, biotechnology firms, and analytical testing organizations strictly for In-Vitro Scientific Research, Reference Calibration, and Non-Clinical Preclinical Evaluation. They may not be imported, marketed, or re-packaged for human consumption or dietary supplementation without explicit Health Canada DIN/NPN clinical trials approval.
Every single production lot passes through strict multi-instrumental qualification before release. We verify absolute chemical identity and stereochemical alignment using High-Performance Liquid Chromatography (HPLC) coupled with Diode Array Detection (DAD), Proton Nuclear Magnetic Resonance (1H-NMR), and Liquid Chromatography-Mass Spectrometry (LC-MS). All original chromatograms and Certificates of Analysis (COA) are supplied prior to shipment.
Orders dispatched to Canadian metropolitan centers—including Toronto, Montreal, Vancouver, Calgary, and Ottawa—typically arrive within 5 to 9 business days via express air courier services. All shipments feature continuous end-to-end tracking, export declaration documentation, and moisture-proof, shock-absorbent multi-layer packaging.
To support both exploratory university pilot assays and commercial-scale contract manufacturing programs, our MOQs are structured flexibly: starting from 10 grams to 50 grams for reference standard testing and initial compound screening, scaling seamlessly to 1 kg, 10 kg, and 100 kg drums for enterprise research programs.
Yes. We actively encourage and welcome third-party verification by ISO/IEC 17025 accredited analytical laboratories (such as Janoshik, MZ Biolabs, or accredited Canadian universities). Our factory maintains a batch-retention archive for every synthesized lot, ensuring complete accountability and reproducibility.
Fine powders are sealed within pharmaceutical-grade, heavy-duty polyethylene inner bags, vacuum-sealed under inert nitrogen blanket gas, and inserted into heat-welded multi-layer metallic mylar foil bags with food-grade silica desiccants. Light-sensitive compounds are isolated in opaque, UV-blocking barriers.
Discover our comprehensive inventory of small-molecule reference powders and advanced lyophilized peptides available for immediate Canadian laboratory dispatch.
